Neurovascular Devices Market Overview by Companies, Drug Profile and Development by Companies 2023

Market Scenario
The Global Neuroblastoma Market is expected to grow steadily over the forecast period. It is projected that the market held a market value of USD 2.60 billion in 2016 and is projected to grow at a CAGR of 3.7% over the forecast period. Neuroblastoma is a common cancer detected in infants. Neuroblastoma develops from immature nerve cells found in various parts of the body. It most commonly occurs in children or young ones below 5 years old. The patient having neuroblastoma may cause symptoms such as backbone pain, weight loss, abdominal pain, enlarged stomach, bulging eyes, weight, crankiness, anemia, fever, bone pain, dark circles around the eyes, weakness, high blood pressure, and constipation or diarrhea.
GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/6555
The factors such as a mutation in germline cells, change in lifestyle and family history of neuroblastoma may cause this disease. In some cases, it may cause due to the use of fertility drugs, maternal use of hair dye, infection, and, atopy. According to the American Childhood Cancer Organization and the International Agency for Research on Cancer (IARC) 2016 report release, it was estimated that approximately 80,000 deaths are caused by childhood cancer globally. Such an increasing case of childhood cancer every year may support this market positively. However, due to the late effects associated with neuroblastoma treatment such as loss of some organ function or hearing loss and others may restrain the market growth. Also, the high cost of this therapy over the conventional treatment or side effects associated with the treatment can hamper the market growth. Also, the dearth of skilled healthcare professionals can hamper the market growth over the forecast period.
Segmentation
The global neuroblastoma market has been segmented into diagnostics, treatment, and end user.
The market, on the basis of diagnostics, has been segmented into various tests, MIBG scan, imaging, and biopsy. The tests are further sub-segmented into bone marrow, tissue, urine, and blood.
The market, by treatment, has been segmented into surgery, chemotherapy, radiation therapy, stem cell transplant, immunotherapy, and monoclonal antibody treatment. The market, by end user, has been segmented into hospitals ambulatory surgical centers, diagnostic centers, research centers, and others.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The neuroblastoma market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European neuroblastoma market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The neuroblastoma market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The neuroblastoma market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players
United Therapeutics Corp., APEIRON Biologics AG, LUMITOS AG, NANTGE Healthcare, Pfizer Inc., GL Pharm Tech Corporation, Aetna Inc, RxStrategies, Inc., and others are some of the key players in the global neuroblastoma market.

Table of Content: Key Points
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Neuroblastoma Market, By Diagnosis
Chapter 7. Global Neuroblastoma Market, By Treatment
Chapter 8. Global Neuroblastoma Market, By End-Users
Chapter 9. Global Neuroblastoma Market, By Region
…Continued
Access full report now: https://www.marketresearchfuture.com/reports/neuroblastoma-market-6555
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.